Modified GRF (1-29), Ipamorelin, GHRP-2 Blend is a lyophilized peptide mixture supplied exclusively for controlled laboratory research and analytical applications. It combines three synthetic research materials commonly evaluated in GH-axis, receptor-binding, and peptide-characterization models.
This product is not intended for human or animal consumption. It is not a drug, dietary supplement, food, cosmetic, or medical product and is not intended for diagnostic, therapeutic, or veterinary applications.
NordSci provides lot-specific analytical documentation to help laboratories verify product identity, purity, and quality-control information.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Modified GRF (1-29), Ipamorelin, GHRP-2 Blend is a lyophilized peptide mixture supplied exclusively for controlled laboratory research and analytical evaluation. The formulation combines three synthetic research materials commonly examined in GH-axis, receptor-binding, and peptide-characterization models.
Modified GRF (1-29) is a synthetic growth hormone-releasing hormone analog. Ipamorelin and GHRP-2 are synthetic ligands associated with growth hormone secretagogue receptor research. The combined format enables laboratories to evaluate multiple peptide components within the same standardized research sample.
This product is not intended for human or animal consumption. It is not a drug, dietary supplement, food, cosmetic, or medical product and is not intended for diagnostic, therapeutic, clinical, or veterinary applications.
Modified GRF (1-29), Ipamorelin, GHRP-2 Blend – Research Specifications:
| Format | Lyophilized research material |
| Contents | Modified GRF (1-29), Ipamorelin, and GHRP-2 |
| Chemical Classification | Synthetic peptide blend |
| Molecular Formula | No single molecular formula applies to the combined blend |
| Molecular Weight | Component-specific; consult the available technical and lot documentation |
| Appearance | Lyophilized powder |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis for available analytical data |
| Testing Documentation | Lot-specific analytical documentation is available through the COA Library |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture according to laboratory procedures |
| Intended Application | Controlled laboratory research and analytical evaluation only |
| Restrictions | Not for human or animal consumption or diagnostic, therapeutic, clinical, veterinary, food, cosmetic, or supplement use |
Modified GRF (1-29), Ipamorelin, GHRP-2 Blend is a multi-component research material containing one synthetic GHRH analog and two synthetic growth hormone secretagogue receptor ligands.
Modified GRF (1-29) is examined in laboratory models involving GHRH receptor interactions and GH-axis signaling. Ipamorelin and GHRP-2 are evaluated in research involving ghrelin receptor and growth hormone secretagogue receptor pathways.
The combined formulation may be incorporated into receptor assays, analytical peptide studies, comparative laboratory models, and method-development workflows. Researchers can evaluate the mixture alongside individual reference compounds, laboratory controls, or alternative formulations under predefined experimental conditions.
Researchers interested in examining the materials individually may reference the product pages for CJC-1295 without DAC, Ipamorelin, and GHRP-2.
Important Research Notice: Lot-specific Certificates of Analysis are available for identity, purity, procurement, and internal quality-control review.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR DIAGNOSTIC, THERAPEUTIC, CLINICAL, VETERINARY, FOOD, COSMETIC, OR SUPPLEMENT USE.
The blend may be evaluated in controlled laboratory models designed to characterize molecular interactions associated with GH-axis signaling.
Researchers may use validated assay systems to examine interactions involving GHRH-related and ghrelin receptor-related pathways under controlled laboratory conditions.
The material may be incorporated into laboratory workflows involving identity confirmation, purity assessment, chromatographic analysis, mass-based analytical methods, or stability evaluation.
Laboratories may compare the standardized peptide mixture with individual reference compounds, control materials, or alternative formulations to document differences observed under consistent assay conditions.
Handle Modified GRF (1-29), Ipamorelin, GHRP-2 Blend only in qualified laboratory facilities using appropriate personal protective equipment, contamination-control practices, calibrated instruments, and documented standard operating procedures.
Protocol Design Considerations: Laboratories should document lot numbers, storage history, assay conditions, instrumentation, environmental variables, sampling intervals, and analytical methods to maintain sample traceability and experimental consistency.
No dosing, application, clinical-use, or in-vivo procedural guidance is provided. This product must not be used in humans or animals.
All experimental work must be conducted by qualified researchers in appropriately equipped laboratory facilities.
Lot-specific Certificates of Analysis provide available identity, purity, and quality-control information for the corresponding research material. Laboratories should review the applicable documentation before incorporating the product into an analytical workflow.
COA documentation is intended for material verification, procurement records, internal audits, and laboratory traceability. It does not establish approval for human or animal use or for diagnostic, therapeutic, clinical, veterinary, food, cosmetic, or supplement applications.
NordSci Peptides supplies Modified GRF (1-29), Ipamorelin, GHRP-2 Blend exclusively as a laboratory research material. Product selection should be based on technical specifications, lot-specific analytical documentation, institutional requirements, and the parameters of the intended laboratory protocol.
IMPORTANT: This material is not approved for human or animal consumption. Purchasers are responsible for complying with all applicable laws, regulations, institutional policies, and laboratory safety requirements.
